Dergiler / Türk Geriatri Dergisi / 2020 / Cilt: 23 - Sayı: 4

FACTORS AFFECTING FRAILTY SYNDROME IN ELDERLY CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS AND ITS RELATIONSHIP WITH SYSTEMIC INFLAMMATION

Sayfa
446–454
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Routine assessment offrailty in chronic obstructive lung disease outpatients may allow early interventions,including referral to physical and respiratory rehabilitation, geriatric and nutritionalspecialists to improve physical performance and quality of life of these patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Introduction: The aim was to identify the factors affecting the frailty syndromein elderly chronic obstructive lung disease patients and to investigate its relationshipwith systemic inflammation.Materials and Method: 61 stable patients (ages of 65-84) were included.Demographic data, body mass index, comorbidities, annual number of exacerbationswere recorded.
📊
Temel Bulgular & Veri:Patients were classified into groups A,B,C&D accordingto GOLD chronic obstructive lung disease guideline by annual exacerbation rateand dyspnea score.
💡
Sonuç & Katkı:Routine assessment offrailty in chronic obstructive lung disease outpatients may allow early interventions,including referral to physical and respiratory rehabilitation, geriatric and nutritionalspecialists to improve physical performance and quality of life of these patients.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Introduction: The aim was to identify the factors affecting the frailty syndromein elderly chronic obstructive lung disease patients and to investigate its relationshipwith systemic inflammation.Materials and Method: 61 stable patients (ages of 65-84) were included.Demographic data, body mass index, comorbidities, annual number of exacerbationswere recorded. Pulmonary function test, six-minute walk test and Tilburg Frailty Testwere performed in all cases. Patients were classified into groups A,B,C&D accordingto GOLD chronic obstructive lung disease guideline by annual exacerbation rateand dyspnea score. Neutrophil lymphocyte ratio, high sensitive C-reactive protein,IL-6, 8OH-dG, IL-18 levels were studied in serum.Results: According to Tilburg test, 63.9% of the patients were evaluated as frail.There was a relationship between body mass index and Tilburg frailty score (p:0.035);body mass index was lower in the frail group. The number of comorbidities washigher in the frail group (p:0.007). There was a positive correlation between frailtyand the number of drugs used. The frailty score was significantly higher in GOLDgroup B&C than in groups A&D (p: 0.006).The neutrophil lymphocyte ratio was significantly higher in the frail group(p:0.007).Conclusion: Frailty is more frequent in chronic obstructive lung disease patients,especially in those with malnutrition and comorbidities and it is associated with asystemic inflammation marker, neutrophil lymphocyte ratio. Routine assessment offrailty in chronic obstructive lung disease outpatients may allow early interventions,including referral to physical and respiratory rehabilitation, geriatric and nutritionalspecialists to improve physical performance and quality of life of these patients.

🔖

Bu Makaleye Atıf Yap

KARUL, A., GÜLEN, Ş. T., KARADAĞ, F., BİRTEKOCAK, F., MUSTAFAOĞLU, B. T. (2022). FACTORS AFFECTING FRAILTY SYNDROME IN ELDERLY CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS AND ITS RELATIONSHIP WITH SYSTEMIC INFLAMMATION. Türk Geriatri Dergisi, Cilt: 23 - Sayı: 4, 446–454. https://ajindex.com/articles/624071

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Lunenfeld B, Stratton P. The clinical consequences of an ageing world and preventive strategies. Best Pract Res Clin Obstet Gynaecol 2013;27(5):643-59. (PMID:23541823)
  2. Chen X., Mao G., Leng S.X. Frailty syndrome: an overview. Clin Interv Aging 2014;9:433-41. (PMID:24672230)
  3. Tudorache E., Fildan A.P., Frandes M., Dantes E., Tofolean D.E. Aging and extrapulmonary effects of chronic obstructive pulmonary disease. Clin Interv Aging 2017;12:1281-87. (PMID:28860729)
  4. Arslan M, Meltem K.E, Sözmen M et al. The Turkish adaptation of the Tilburg frailty indicator: a validity and reliability study. Turkish Journal of Geriatrics 2018;21(2):173-83
  5. Vestbo J, Hurd S.S, Agusti A.G et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187(4):347-65. (PMID:22878278)
  6. Fabbri L.M, Luppi F, Beghe B, Rabe K.F. Complex chronic comorbidities of COPD. Eur Respir J 2008;31(1):204-12. (PMID:18166598)
  7. Barnes P.J, Celli B.R. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33(5):1165-85. (PMID:19407051)
  8. Yazici O, Tas Gulen S, Eryilmaz U, Omurlu I.K. The evaluation of cardiac functions according to chronic obstructive pulmonary disease groups. Aging Male 2020;23(2):106-11. (PMID:31037993)
  9. Kusunose M, Oga T, Nakamura S, Hasegawa Y, Nishimura K. Frailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities? BMJ Open Respir Res 2017; 4(1): e000196. Published 2017 Jul 3. (doi:10.1136/bmjresp-2017-000196.) (PMID:28883929)
  10. Limpawattana P, Putraveephong S, Inthasuwan P, Boonsawat W, Theerakulpisut D, Chindaprasirt J. Frailty syndrome in ambulatory patients with COPD. Int J Chron Obstruct Pulmon Dis 2017;12:1193-98. (PMID:28458530)
  11. Bousquet J, Dinh-Xuan A.T, Similowski T. et al. Should we use gait speed in COPD, FEV1 in frailty and dyspnoea in both? Eur Respir J 2016;48(2):315- 19. (PMID:27478189)
  12. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019 Report. [Internet]. Available from: https://goldcopd.org/wpcontent/uploads/2018/11/GOLD-2019-v1.7-FINAL14Nov2018-WMS.pdf. Accessed:05.10.2020
  13. Miller M.R, Crapo R, Hankinson J. et al. General considerations for lung function testing. Eur Respir J 2005;26(1):153-61. (PMID:15994402)
  14. Turner G, Clegg A. British Geriatrics